Dr Lal Pathlabs' Q3 FY 2025-26 Quarterly Results
- 31 Jan 2026
Result Summary
- Dr Lal Pathlabs Ltd reported a 9.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.0%.
- Its expenses for the quarter were down by 4.0% QoQ and up 9.6% YoY.
- The net profit decreased 39.9% QoQ and decreased 6.8% YoY.
- The earnings per share (EPS) of Dr Lal Pathlabs Ltd stood at 5.41 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 684.20 | 755.40 | 621.80 | -9.4% | 10.0% |
Total Expenses | 529.80 | 551.80 | 483.50 | -4.0% | 9.6% |
Profit Before Tax | 124.30 | 203.60 | 138.30 | -38.9% | -10.1% |
Tax | 32.90 | 51.40 | 40.20 | -36.0% | -18.2% |
Profit After Tax | 91.40 | 152.20 | 98.10 | -39.9% | -6.8% |
Earnings Per Share | 5.41 | 18.01 | 11.58 | -70.0% | -53.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Dr Lal Pathlabs Ltd is a prominent diagnostics and healthcare company in India, providing a comprehensive range of pathology and diagnostic services. The company is well-known for its extensive network of laboratories and collection centers across the country, offering services such as blood tests, urine tests, and various other diagnostic tests. Dr Lal Pathlabs has established a strong reputation in the healthcare industry for its quality services and expansive reach. As of the latest available information, the company continues to maintain its position as a leading diagnostic service provider in India. Any additional recent major developments specific to the company are not available in the provided data.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Dr Lal Pathlabs Ltd reported total income of ₹684.20 crores. This represents a decrease of 9.4% compared to the previous quarter (Q2FY26), where the total income was ₹755.40 crores. However, when compared to the same quarter in the previous year (Q3FY25), the total income increased by 10.0% from ₹621.80 crores. The year-over-year growth indicates a positive trend in revenue generation, despite the quarter-over-quarter decline. The company continues to demonstrate its ability to increase revenue on an annual basis, aligning with its strategic goals to expand its market presence.
Profitability
The profitability metrics for Q3FY26 reveal a profit before tax (PBT) of ₹124.30 crores, showing a significant decline of 38.9% compared to the previous quarter's PBT of ₹203.60 crores. On a year-over-year basis, the PBT decreased by 10.1% from ₹138.30 crores in Q3FY25. The tax expense for Q3FY26 was ₹32.90 crores, representing a reduction of 36.0% quarter-over-quarter and 18.2% year-over-year. Profit after tax (PAT) for Q3FY26 was ₹91.40 crores, marking a decrease of 39.9% from the previous quarter's PAT of ₹152.20 crores, and a decline of 6.8% compared to the same quarter last year. The earnings per share (EPS) were ₹5.41, which decreased by 70.0% quarter-over-quarter and by 53.3% year-over-year. The data reflects a challenging quarter in terms of profitability metrics when viewed against both the preceding quarter and the same period last year.
Operating Metrics
The operating expenses for Q3FY26 totaled ₹529.80 crores, which is a decrease of 4.0% from the previous quarter where expenses were ₹551.80 crores. Compared to Q3FY25, there was an increase of 9.6% from ₹483.50 crores. The reduction in expenses quarter-over-quarter suggests effective cost management during this period, while the year-over-year increase aligns with the growth in total income. The company's operating metrics, including expense management, are essential in maintaining overall financial health, affecting both profitability and revenue outcomes. The balance between income growth and expense management remains a critical area for the company to address in maintaining and improving operational efficiency.